investigational treatment

investigational treatment

An intervention under investigation in a clinical study.
References in periodicals archive ?
Dermira announced that the investigational treatment olumacostat glasaretil did not meet the co-primary endpoints in its two Phase 3 pivotal trial in patients ages nine years and older with moderate-to-severe acne vulgaris.
The FDA's Breakthrough Therapy Designation program is aimed at accelerating the development and review of medicines with preliminary clinical evidence that indicates that the investigational treatment is likely to demonstrate substantial improvement over present therapies on one or more clinically significant endpoints.
Charleston Laboratories is now centralising its comprehensive acute pain portfolio to treat acute pain and opioid-induced nausea and vomiting, and accelerating the process to bring investigational treatment CL-108 to market.
It may be premature to ask, but we highlight this investigational treatment as a notable scientific development that might possibly help us overcome the disease in the long run.
Biogen and Ionis Pharmaceuticals' Phase III study evaluating SPINRAZA (nusinersen), an investigational treatment for spinal muscular atrophy (SMA), met the primary endpoint at the interim analysis.
Emtricitabine is also an essential component of the Quad, an investigational treatment that combines four Gilead medicines in a once-daily, single tablet regimen for the treatment of HIV.
PHOENIX--An investigational treatment for depression exploits the benefits of opioids while counteracting the mu opioid agonism thought to contribute to abuse potential.
PHOENIX -- An investigational treatment for depression exploits the benefits of opioids while counteracting the mu opioid agonism thought to contribute to abuse potential.
The investigational treatment used the company's MarrowStim device for point-of-care concentration of the autologous BMA.
The investigational treatment led to improvements in core symptoms at school and at home, compared with placebo.
has announced that patient enrollment has been completed in an open-label, randomized Phase III clinical study of decitabine, an investigational treatment for advanced myelodysplastic syndrome (MDS).

Full browser ?